BlossomHill Therapeutics Appoints Geoff Oxnard as Chief Medical Officer and Executive Vice President, and Ashley Preston as Senior Vice President and Head of Regulatory Affairs and Quality Assurance
Position
Vice President
Company
BlossomHill Therapeutics
San DiegoBiotechnologyHealthcareHealth CareDescription
BlossomHill Therapeutics, Inc. announced the appointment of Geoff Oxnard, M.D., as Chief Medical Officer and Executive Vice President, and Ashley Preston, Ph.D., as Senior Vice President and Head of Regulatory Affairs and Quality Assurance.
Quick answer
BlossomHill Therapeutics Appoints Geoff Oxnard as Chief Medical Officer and Executive Vice President, and Ashley Preston as Senior Vice President and Head of Regulatory Affairs and Quality Assurance (January 6, 2025). BlossomHill Therapeutics is based in San Diego, California, United States.
- Who is the new Vice President at BlossomHill Therapeutics?
- BlossomHill Therapeutics named Ashley Preston Vice President, announced January 6, 2025.
- What did BlossomHill Therapeutics announce on January 6, 2025?
- BlossomHill Therapeutics, Inc. announced the appointment of Geoff Oxnard, M.D., as Chief Medical Officer and Executive Vice President, and Ashley Preston, Ph.D., as Senior Vice President and Head of Regulatory Affairs and Quality Assurance.
- What does BlossomHill Therapeutics do?
- BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
- Where is BlossomHill Therapeutics based?
- BlossomHill Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Amylyx Pharmaceuticals (January 6, 2025), Harrow (January 7, 2025), TriSalus Life Sciences (January 8, 2025) and Verastem Oncology (January 15, 2025) also announced leadership changes within 45 days of BlossomHill Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025)
- Harrow Appoints Amir H. Shojaei as Chief Scientific Officer (January 7, 2025)
- TriSalus Appoints James (Jim) Young as Chief Financial Officer and Announces Promotions for Dr. Richard B. Marshak and Jodi Devlin (January 8, 2025)
- Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer (January 15, 2025)
- Sanara MedTech Inc. Appoints Elizabeth Taylor as Chief Financial Officer and Michael McNeil as Chief Accounting Officer and Chief Administrative Officer (January 21, 2025)
- GenomOncology Appoints Dr. Jonathan 'Jack' Lord, M.D. as Chief Innovation Officer and Chief Operating Officer (December 19, 2024)
Who to call at BlossomHill Therapeutics, and when
A new leader at BlossomHill Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BlossomHill Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BlossomHill Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BlossomHill Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BlossomHill Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BlossomHill Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.